Eljabo N, Nikolic N, Carkic J, Jelovac D, Lazarevic M, Tanic N, et al. Genetic and epigenetic alterations in the tumour, tumour margins, and normal buccal mucosa of patients with oral cancer. Int J Oral Maxillofac Surg. 2018;47(8):976–82.
Article
CAS
PubMed
Google Scholar
Curtius K, Wright NA, Graham TA. An evolutionary perspective on field cancerization. Nat Rev Cancer. 2018;18(1):19–32.
Article
CAS
PubMed
Google Scholar
Slaughter DP, Southwick HW, Smejkal W. “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer. 1953;6(5):963–8.
Article
CAS
PubMed
Google Scholar
Bosch FX, Ouhayoun J-P, Bader BL, Collin C, Grund C, Lee I, et al. Extensive changes in cytokeratin expression patterns in pathologically affected human gingiva. Virchows Archiv B. 1989;58(1):59.
Article
CAS
Google Scholar
Bongers V, Snow GB, De Vries N, Braakhuis BJ. Potential early markers of carcinogenesis in the mucosa of the head and neck using exfoliative cytology. J Pathol. 1996;178(3):284–9.
Article
CAS
PubMed
Google Scholar
Bartkova J, Lukas J, Müller H, Strauss M, Gusterson B, Bartek J. Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Can Res. 1995;55(4):949–56.
CAS
Google Scholar
Bloching MM, Soulsby H, Naumann A, Aust W, Merkel D, Braun T, et al. Tumor risk assessment by means of immunocytochemical detection of early pre-malignant changes in buccal smears. Oncol Rep. 2008;19(6):1373–9.
PubMed
Google Scholar
Shin DM, Ro JY, Hong WK, Hittelman WN. Dysregulation of epidermal growth factor receptor expression in premalignant lesions during head and neck tumorigenesis. Can Res. 1994;54(12):3153–9.
CAS
Google Scholar
Van Oijen M, Rijksen G, Broek Ft, Slootweg PJ. Increased expression of epidermal growth factor receptor in normal epithelium adjacent to head and neck carcinomas independent of tobacco and alcohol abuse. Oral Dis. 1998;4(1):4–8.
Article
PubMed
Google Scholar
Grandis JR, Tweardy DJ. Elevated levels of transforming growth factor α and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Can Res. 1993;53(15):3579–84.
CAS
Google Scholar
van Oijen MG, Gilsing MMA, Rijksen G, Hordijk GJ, Slootweg PJ. Increased number of proliferating cells in oral epithelium from smokers and ex-smokers. Oral Oncol. 1998;34(4):297–303.
Article
PubMed
Google Scholar
Birchall MA, Schock E, Harmon BV, Gobe G. Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study. Oral Oncol. 1997;33(6):419–25.
Article
CAS
PubMed
Google Scholar
El-Gazzar R, Macluskey M, Ogden GR. Evidence for a field change effect based on angiogenesis in the oral mucosa? A brief report. Oral Oncol. 2005;41(1):25–30.
Article
CAS
PubMed
Google Scholar
Cruz IB, Snijders PJ, Meijer CJ, Braakhuis BJ, Snow GB, Walboomers JM, et al. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma. J Pathol. 1998;184(4):360–8.
Article
CAS
PubMed
Google Scholar
Lavieille JP, Brambilla E, Riva-Lavieille C, Reyt E, Charachon R, Brambilla C. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck. Acta Otolaryngol. 1995;115(2):334–9.
Article
CAS
PubMed
Google Scholar
Nakanishi Y, Noguchi M, Mukai K, Matsuno Y, Hirohashi S, Saikawa M, et al. p53 expression in multicentric squamous cell carcinoma and surrounding squamous epithelium of the upper aerodigestive tract. Immunohistochemical analysis of 95 lesions. Cancer. 1995;75(7):1657–62.
Article
CAS
PubMed
Google Scholar
Nees M, Homann N, Discher H, Andl T, Enders C, Herold-Mende C, et al. Expression of mutated p53 occurs in tumor-distant epithelia of head and neck cancer patients: a possible molecular basis for the development of multiple tumors. Can Res. 1993;53(18):4189–96.
CAS
Google Scholar
van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol. 1999;187(4):469–74.
Article
PubMed
Google Scholar
Waridel F, Estreicher A, Bron L, Flaman JM, Fontolliet C, Monnier P, et al. Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene. 1997;14(2):163–9.
Article
CAS
PubMed
Google Scholar
Van Roy FM, McCrea PD. A role for Kaiso–p120ctn complexes in cancer? Nat Rev Cancer. 2005;5(12):956–64.
Article
PubMed
CAS
Google Scholar
Kelly KF, Daniel JM. POZ for effect–POZ-ZF transcription factors in cancer and development. Trends Cell Biol. 2006;16(11):578–87.
Article
CAS
PubMed
Google Scholar
Pierre CC, Hercules SM, Yates C, Daniel JM. Dancing from bottoms up–roles of the POZ-ZF transcription factor Kaiso in cancer. Biochim Biophys Acta Rev Cancer. 2019;1871(1):64–74.
Article
CAS
PubMed
Google Scholar
Xue X, Zhang J, Lan H, Xu Y, Wang H. Kaiso protects human umbilical vein endothelial cells against apoptosis by differentially regulating the expression of B-cell CLL/lymphoma 2 family members. Sci Rep. 2017;7(1):1–16.
CAS
Google Scholar
Bassey-Archibong BI, Rayner LG, Hercules SM, Aarts CW, Dvorkin-Gheva A, Bramson JL, et al. Kaiso depletion attenuates the growth and survival of triple negative breast cancer cells. Cell Death Dis. 2017;8(3):e2689.
Article
CAS
PubMed
PubMed Central
Google Scholar
Koh D-I, Han D, Ryu H, Choi W-I, Jeon B-N, Kim M-K, et al. KAISO, a critical regulator of p53-mediated transcription of CDKN1A and apoptotic genes. Proc Natl Acad Sci. 2014;111(42):15078–83.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vermeulen JF, van de Ven RA, Ercan C, van der Groep P, van der Wall E, Bult P, et al. Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer. PLoS ONE. 2012;7(5):e37864.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jones J, Wang H, Karanam B, Theodore S, Dean-Colomb WM, Welch DR, et al. Nuclear localization of Kaiso as a prognostic biomarker and promotion of EMT in infiltrating ductal breast carcinomas. Am Soc Clin Oncol. 2014.
Bassey-Archibong BI, Hercules SM, Rayner LG, Skeete DH, Connell SPS, Brain I, et al. Kaiso is highly expressed in TNBC tissues of women of African ancestry compared to Caucasian women. Cancer Causes Control. 2017;28(11):1295–304.
Article
PubMed
PubMed Central
Google Scholar
Kwiecien JM, Bassey-Archibong BI, Dabrowski W, Rayner LG, Lucas AR, Daniel JM. Loss of Kaiso expression in breast cancer cells prevents intra-vascular invasion in the lung and secondary metastasis. PLoS ONE. 2017;12(9):e0183883.
Article
PubMed
PubMed Central
CAS
Google Scholar
Dai S-D, Wang Y, Miao Y, Zhao Y, Zhang Y, Jiang G-Y, et al. Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer. BMC Cancer. 2009;9(1):1–13.
Article
CAS
Google Scholar
Jones J, Wang H, Zhou J, Hardy S, Turner T, Austin D, et al. Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells. Am J Pathol. 2012;181(5):1836–46.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang H, Liu W, Black S, Turner O, Daniel JM, Dean-Colomb W, et al. Kaiso, a transcriptional repressor, promotes cell migration and invasion of prostate cancer cells through regulation of miR-31 expression. Oncotarget. 2016;7(5):5677.
Article
PubMed
Google Scholar
Jones J, Mukherjee A, Karanam B, Davis M, Jaynes J, Reams RR, et al. African Americans with pancreatic ductal adenocarcinoma exhibit gender differences in Kaiso expression. Cancer Lett. 2016;380(2):513–22.
Article
CAS
PubMed
PubMed Central
Google Scholar
SeyedJafari SM, Hunger R. IHC optical density score: a new practical method for quantitative immunohistochemistry image analysis. Appl Immunohistochem Mol Morphol. 2017;25(1):e12–3.
Article
Google Scholar
BRODERS AC. The microscopic grading of cancer. The surgical clinics of north America. 1941;21:947–62.
Bryne M, Koppang HS, Lilleng R, Kjærheim Å. Malignancy grading of the deep invasive margins of oral squamous cell carcinomas has high prognostic value. J Pathol. 1992;166(4):375–81.
Article
CAS
PubMed
Google Scholar
Boxberg M, Jesinghaus M, Dorfner C, Mogler C, Drecoll E, Warth A, et al. Tumour budding activity and cell nest size determine patient outcome in oral squamous cell carcinoma: proposal for an adjusted grading system. Histopathology. 2017;70(7):1125–37.
Article
PubMed
Google Scholar
van Houten VM, Tabor MP, van den Brekel MW, Alain Kummer J, Denkers F, Dijkstra J, et al. Mutated p53 as a molecular marker for the diagnosis of head and neck cancer. J Pathol. 2002;198(4):476–86.
Article
PubMed
CAS
Google Scholar
El-Naggar AK, Lai S, Luna MA, Zhou X-D, Weber RS, Goepfert H, et al. Sequential p53 mutation analysis of pre-invasive and invasive head and neck squamous carcinoma. Int J Cancer. 1995;64(3):196–201.
Article
CAS
PubMed
Google Scholar
Reda E, Reda N. Over expression of p53 and p21 in normal oral mucosa adjacent to resected squamous cell carcinomas. 2005.
Google Scholar
Izzo JG, Papadimitrakopoulou VA, Li XQ, Ibarguen H, Lee JS, Ro JY, et al. Dysregulated cyclin D1 expression early in head and neck tumorigenesis: in vivo evidence for an association with subsequent gene amplification. Oncogene. 1998;17(18):2313–22.
Article
CAS
PubMed
Google Scholar
Ortiz BH, Ailawadi M, Colitti C, Muto MG, Deavers M, Silva EG, et al. Second primary or recurrence? Comparative patterns of p53 and K-ras mutations suggest that serous borderline ovarian tumors and subsequent serous carcinomas are unrelated tumors. Can Res. 2001;61(19):7264–7.
CAS
Google Scholar
Werkmeister R, Brandt B, Joos U. The erbB oncogenes as prognostic markers in oral squamous cell carcinomas. Am J Surg. 1996;172(6):681–3.
Article
CAS
PubMed
Google Scholar
Szymańska K, Levi JE, Menezes A, Wünsch-Filho V, Eluf-Neto J, Koifman S, et al. TP53 and EGFR mutations in combination with lifestyle risk factors in tumours of the upper aerodigestive tract from South America. Carcinogenesis. 2010;31(6):1054–9.
Article
PubMed
CAS
Google Scholar
Astekar M, Joshi A, Ramesh G, Metgud R. Expression of vascular endothelial growth factor and microvessel density in oral tumorigenesis. J Oral Maxillofac Pathol. 2012;16(1):22.
Article
PubMed
PubMed Central
Google Scholar
López-Blanc SA, Collet AM, Gandolfo MS, Femopase F, Hernández SL, Tomasi VH, et al. Nucleolar organizer regions (AgNOR) and subepithelial vascularization as field cancerization markers in oral mucosa biopsies of alcoholic and smoking patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;108(5):747–53.
Article
PubMed
Google Scholar
Daniel: The p120 ctn-binding partner Kaiso is a bi-modal... - Google Scholar [
Buck-Koehntop BA, Stanfield RL, Ekiert DC, Martinez-Yamout MA, Dyson HJ, Wilson IA, et al. Molecular basis for recognition of methylated and specific DNA sequences by the zinc finger protein Kaiso. Proc Natl Acad Sci. 2012;109(38):15229–34.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhenilo S, Deyev I, Litvinova E, Zhigalova N, Kaplun D, Sokolov A, et al. DeSUMOylation switches Kaiso from activator to repressor upon hyperosmotic stress. Cell Death Differ. 2018;25(11):1938–51.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cofre J, Menezes JR, Pizzatti L, Abdelhay E. Knock-down of Kaiso induces proliferation and blocks granulocytic differentiation in blast crisis of chronic myeloid leukemia. Cancer Cell Int. 2012;12(1):1–14.
Article
CAS
Google Scholar
Pierre C. Kaiso: a novel mediator of intestinal inflammation and tumorigenesis [PhD Thesis]. 2015.
Google Scholar